Corbus Pharmaceuticals Holdings, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $9.0M | $17.9M | $15.0M |
| FY2017 | $9.2M | $67.0M | $62.5M |
| FY2018 | $19.5M | $47.0M | $41.7M |
| FY2019 | $43.0M | $49.1M | $31.7M |
| FY2020 | $57.0M | $102.3M | $85.4M |
| FY2021 | $38.6M | $107.7M | $25.0M |
| FY2022 | $33.3M | $66.3M | $17.0M |
| FY2023 | $35.2M | $28.3M | $13.7M |
| FY2024 | $13.5M | $155.9M | $17.2M |
| FY2025 | $20.7M | $168.2M | $28.5M |